Vestibular Versus Sublingual Route of AIT Tablets

PHASE4CompletedINTERVENTIONAL

Enrollment

172

Participants

Timeline

Start Date

October 25, 2021

Primary Completion Date

April 5, 2022

Study Completion Date

April 21, 2022

Conditions

Hypersensitivity

Interventions

DRUG

tree 12 SQ-Bet

DAILY DOSE OF AIT TABLET

DRUG

GRASS 2800 BAU

DAILY DOSE OF AIT TABLET

DRUG

RAGWEED 12 AMB A 1-U

DAILY DOSE OF AIT TABLET

DRUG

HDM 12 SQ-HDM

DAILY DOSE OF AIT TABLET

Trial Locations (1)

Clinique specialisee en allergie de la capitale, Québec

All Listed Sponsors

collaborator

ALK-Abelló A/S

INDUSTRY

lead

Clinique Spécialisée en Allergies de la Capitale

OTHER

NCT05119751 - Vestibular Versus Sublingual Route of AIT Tablets | Biotech Hunter | Biotech Hunter